Nasim Tabrizi

581 total citations
40 papers, 326 citations indexed

About

Nasim Tabrizi is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Nasim Tabrizi has authored 40 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Nasim Tabrizi's work include Epilepsy research and treatment (15 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Multiple Sclerosis Research Studies (7 papers). Nasim Tabrizi is often cited by papers focused on Epilepsy research and treatment (15 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Multiple Sclerosis Research Studies (7 papers). Nasim Tabrizi collaborates with scholars based in Iran, United States and Canada. Nasim Tabrizi's co-authors include Ebrahim Salehifar, Razieh Avan, Masoud Etemadifar, Jafar Mehvari Habibabadi, Abbas Alipour, Ghasem Janbabaei, Seyed-Hossein Abtahi, Mohammad Saadatnia, Alireza Dehghani and Alireza Minagar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Epilepsy Research and Epilepsy & Behavior.

In The Last Decade

Nasim Tabrizi

38 papers receiving 316 citations

Peers

Nasim Tabrizi
Shih Hui Lim Singapore
Julia Åivo Finland
Linda Rolf Netherlands
Klaus Krueger Germany
Bijal Mehta United States
Ray Zhang United States
Jan Kochanowski Poland
Melanie R. Ursell Canada
Sebahattin Vurucu Türkiye
Shih Hui Lim Singapore
Nasim Tabrizi
Citations per year, relative to Nasim Tabrizi Nasim Tabrizi (= 1×) peers Shih Hui Lim

Countries citing papers authored by Nasim Tabrizi

Since Specialization
Citations

This map shows the geographic impact of Nasim Tabrizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasim Tabrizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasim Tabrizi more than expected).

Fields of papers citing papers by Nasim Tabrizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasim Tabrizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasim Tabrizi. The network helps show where Nasim Tabrizi may publish in the future.

Co-authorship network of co-authors of Nasim Tabrizi

This figure shows the co-authorship network connecting the top 25 collaborators of Nasim Tabrizi. A scholar is included among the top collaborators of Nasim Tabrizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasim Tabrizi. Nasim Tabrizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabrizi, Nasim, et al.. (2025). A long-standing undiagnosed case of vitamin B12 deficiency: a case report. Journal of Medical Case Reports. 19(1). 151–151.
2.
3.
Salehifar, Ebrahim, Emran Habibi, Reza Alizadeh‐Navaei, et al.. (2024). Effect of Melissa officinalis on Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Randomized Trial. International Journal of Hematology-Oncology and Stem Cell Research. 18(2). 165–173. 1 indexed citations
4.
Cheraghmakani, Hamed, et al.. (2022). Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial. Epilepsy & Behavior. 136. 108938–108938. 1 indexed citations
5.
Tabrizi, Nasim & Athena Sharifi‐Razavi. (2022). Potential risk of liver injury in epileptic patients during COVID-19 pandemic. World Journal of Virology. 11(6). 467–476. 2 indexed citations
6.
Habibabadi, Jafar Mehvari, et al.. (2021). Outcome of epilepsy surgery in lesional epilepsy: Experiences from a developing country. Epilepsy & Behavior. 122. 108221–108221. 7 indexed citations
7.
Salehifar, Ebrahim, et al.. (2020). Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial. Clinical Drug Investigation. 40(3). 249–257. 47 indexed citations
8.
Tabrizi, Nasim & Narges Karimi. (2019). Clinical Epidemiologic Study of Admissions due to Neurologic Diseases during and after Ramadan Fasting,Sari, Iran, 2015. SHILAP Revista de lepidopterología. 29(179). 117–125. 2 indexed citations
9.
Habibabadi, Jafar Mehvari, Nabil F. Saba, Majid Barekatain, Nasim Tabrizi, & Navid Manouchehri. (2018). Establishment of a Database for Drug-Resistant Epilepsy, Isfahan Comprehensive Epilepsy Center, Iran. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Habibabadi, Jafar Mehvari, Shervin Badihian, Nasim Tabrizi, et al.. (2018). Evaluation of dual pathology among drug-resistant epileptic patients with hippocampal sclerosis. Neurological Sciences. 40(3). 495–502. 5 indexed citations
11.
Salehifar, Ebrahim, et al.. (2018). The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial. Journal of Research in Medical Sciences. 23(1). 52–52. 36 indexed citations
12.
Karimi, Narges, et al.. (2017). Prevalence of Carpal Tunnel Syndrome and Associated Risk Factors. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 26(146). 179–184. 5 indexed citations
13.
14.
Badihian, Shervin, et al.. (2017). An Undiagnosed Case of Hypothalamic Hamartoma with a Rare Presentation. Case Reports in Medicine. 2017. 1–5. 1 indexed citations
15.
Karimi, Narges, et al.. (2015). Relationship between Mitochondrial Dysfunction and Multiple Sclerosis: A Review Study. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Fatehi, Farzad, et al.. (2014). Ischemic stroke as a rare manifestation of aluminum phosphide poisoning: a case report.. PubMed. 52(12). 947–9. 6 indexed citations
17.
Tabrizi, Nasim, et al.. (2012). Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Etemadifar, Masoud, Awat Feizi, Seyed‐Hossein Abtahi, et al.. (2012). Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurologica Belgica. 113(3). 257–263. 50 indexed citations
19.
Etemadifar, Masoud, Seyed-Hossein Abtahi, Alireza Dehghani, et al.. (2011). Myasthenia Gravis during the Course of Neuromyelitis Optica. Case Reports in Neurology. 3(3). 268–273. 13 indexed citations
20.
Bashashati, Mohammad, et al.. (2009). Surgical approach to hydrocarbon injection in upper extremities: Case series. International Journal of Surgery. 7(4). 382–386. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih Hui Lim Breakdown of academic impact, for papers by Julia Åivo Breakdown of academic impact, for papers by Linda Rolf Breakdown of academic impact, for papers by Klaus Krueger Breakdown of academic impact, for papers by Bijal Mehta Breakdown of academic impact, for papers by Ray Zhang Breakdown of academic impact, for papers by Jan Kochanowski Breakdown of academic impact, for papers by Melanie R. Ursell Breakdown of academic impact, for papers by Sebahattin Vurucu
Rankless by CCL
2026